DENNIS S. POE
Physician in Boston, MA
License number
Massachusetts MD09086
Issued Date
Aug 2, 1996
Expiration Date
6, 2014
Category
Physician
Type
Allopathic Physician (MD)
Address
Address
Boston, MA
Education
State U. of New York (SUNY Upstate) at Syracuse, Jan 6, 1982
Organization information
See more information about DENNIS S. POE at bizstanding.comDennis S Poe MD
333 Longwood Ave, Boston, MA 02115
Categories:
Neurology Physicians & Surgeons, Otolaryngology Physicians & Surgeons, Pediatrics Physicians & Surgeons, ...
Site:
Phone:
(617) 355-6460 (Phone)
Specialties:
Nasal Disorders
Brands:
Ortho
Products:
Military & Veteran's Services, Orthopedics, Surgery
Payment options:
All Major Cards Accepted, American Express, MasterCard, ...
Additional:
Orthopaedic Surgery Foundation
Professional information
See more information about DENNIS S. POE at trustoria.com
Dr. Dennis S Poe, Boston MA - MD (Doctor of Medicine)
Dr. Dennis S Poe, Boston MA - MD (Doctor of Medicine)
Specialties:
Neurotology
Address:
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6000 (Phone)
Childrens Hosp Bostn Otolrnglgy
300 Longwood Ave SUITE LO-367, Boston 02115
(617) 355-6460 (Phone)
300 Longwood Ave, Boston 02115
(617) 355-6000 (Phone)
Childrens Hosp Bostn Otolrnglgy
300 Longwood Ave SUITE LO-367, Boston 02115
(617) 355-6460 (Phone)
Certifications:
Neurotology, 2004, Otolaryngology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
SUNY Upstate Med Univ
Graduated: 1982
Umass Med Center
Universitiy Chicago Med Center
Graduated: 1987
University Ma Med Center
Graduated: 1983
Otology Group
Graduated: 1988
SUNY Upstate Med Univ
Graduated: 1982
Umass Med Center
Universitiy Chicago Med Center
Graduated: 1987
University Ma Med Center
Graduated: 1983
Otology Group
Graduated: 1988
Dennis S Poe, Boston MA
Dennis S Poe, Boston MA
Specialties:
Ear, Nose & Throat Doctor
Address:
333 Longwood Ave, Boston, MA 02115
300 Longwood Ave, Boston, MA 02115
300 Longwood Ave, Boston, MA 02115
Education:
State University of New York, Upstate Medical University - Doctor of Medicine
Bernard Mitchell Hospital-University of Chicago Hospitals - Residency - Otolaryngology-Head and Neck Surgery
UMass Memorial Medical Center - Memorial Campus - Residency - Surgery
Bernard Mitchell Hospital-University of Chicago Hospitals - Residency - Otolaryngology-Head and Neck Surgery
UMass Memorial Medical Center - Memorial Campus - Residency - Surgery
Board certifications:
American Board of Otolaryngology Certification in Otolaryngology, American Board of Otolaryngology Sub-certificate in Neurotology (Otolaryngology)
Treatments For Immune-Mediated Ear Disorders
Treatments For Immune-Mediated Ear Disorders
US Patent:
2004007, Apr 15, 2004
Filed:
Apr 15, 2003
Appl. No.:
10/414259
Inventors:
Mahboob Rahman - Sharon MA, US
Dennis Poe - Chestnut Hill MA, US
Hyon Choi - Lexington MA, US
Dennis Poe - Chestnut Hill MA, US
Hyon Choi - Lexington MA, US
International Classification:
A61K031/42
US Classification:
514/378000
Abstract:
Disclosed herein are methods for treating immune-mediated ear disorders, such as IMCVDs, or their symptoms, involving administration of a therapeutically-effective amount of a TNF antagonist, such as etanercept or infliximab, or a therapeutically-effective amount of a pyrimidine synthesis inhibitor, such as leflunomide.
Treatments For Immune-Mediated Ear Disorders
Treatments For Immune-Mediated Ear Disorders
US Patent:
2002004, Apr 18, 2002
Filed:
Mar 27, 2001
Appl. No.:
09/818411
Inventors:
Mahboob Rahman - Sharon MA, US
Dennis Poe - Chestnut Hill MA, US
Hyon Choi - Lexington MA, US
Dennis Poe - Chestnut Hill MA, US
Hyon Choi - Lexington MA, US
International Classification:
A61K038/19
US Classification:
424/085100
Abstract:
Disclosed herein are methods for treating immune-mediated ear disorders, such as IMCVDs, or their symptoms, involving administration of a therapeutically-effective amount of a TNF antagonist, such as etanercept or infliximab, or a therapeutically-effective amount of a pyrimidine synthesis inhibitor, such as leflunomide.